Am J Transplant, Volume 22, Suppl 3 Archives - Page 172 of 190 - ATC Abstracts

2022 American Transplant Congress
An International Multi-Institutional Comparison of Liver Transplantation for Hepatocellular Carcinoma: United States, United Kingdom, and Canada
T. Ivanics¹, D. Wallace², M. P. Claasen³, M. Patel⁴, W. Jassem⁵, K. Menon⁵, A. Suddle⁵, N. Heaton⁵, N. Mehta⁶, J. van der Meulen², G. Sapisochin³
¹University of Toronto - University Health Network, Toronto, ON, Canada, ²Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, ³Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada, ⁴Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, ⁵Institute of Liver Studies, King's College Hospital, London, United Kingdom, ⁶UCSF, San Francisco, CA
*Purpose: Hepatocellular carcinoma (HCC) has become a leading indication for liver transplantation (LT) globally. Given the scarcity of organs, the general consensus has been that…
2022 American Transplant Congress
APN-Driven COVID-19 Monitoring Model for Kidney Transplant Patients
J. Yoo, S. Patel, T. Clevy-Schneller, A. Desai, R. Sodhi, D. Jain, S. Akkina
Loyola University Medical Center, Maywood, IL
*Purpose: COVID-19 infection in kidney transplant (KT) recipients is characterized by an unpredictable course and can be life-threatening. Prompt adjustment of immunosuppression and hospitalization when…
2022 American Transplant Congress
Performance of Aged Liver Grafts in a Rat Model of Normothermic Ex Vivo Liver Machine Perfusion
S. Moosburner¹, M. Zimmer¹, J. M. Gassner¹, N. Roschke¹, N. Berndt², J. Michelotto¹, K. H. Hillebrandt¹, J. Pratschke¹, I. M. Sauer¹, N. Raschzok¹
¹Department of Surgery, Experimental Surgery, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, ²Institute of Biochemistry, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
*Purpose: We aimed to characterize the performance of old vs. young liver grafts in a standardized rat model of normothermic ex vivo liver machine perfusion…
2022 American Transplant Congress
Clinical Implications of Robotically Assisted Laparoscopic Donor Nephrectomy: A Single Center Experience
A. Popovic¹, S. Loerzel², M. Hanlon², S. Iskhagi², B. Gallay³, E. Shaban³, J. Leggat³, R. H. Dvorai⁴, S. Narsipur⁵, R. Saidi², R. Shahbazov²
¹College of Medicine, SUNY, Upstate Medical University, Syracuse, NY, ²Surgery, Division of Transplantation, SUNY, Upstate Medical University, Syracuse, NY, ³Medicine, SUNY, Upstate Medical University, Syracuse, NY, ⁴Pathology, SUNY, Upstate Medical University, Syracuse, NY, ⁵SUNY, Upstate Medical University, Syracuse, NY
*Purpose: Robotic assisted live donor nephrectomies (RDN) continue to increase in prevalence over the last years. Prior studies demonstrated outcomes of robotic procedures are no…
2022 American Transplant Congress
Application of Metagenomicnext-Generation Sequencing in the Diagnosis and Treatment of Recurrent Urinary Tract Infections in Kidney Transplant Recipients
W. Duan, X. Tian, X. Wu, G. Cao, T. Yan
Henan Province People's Hospital, Zhengzhou, Henan Province, China
*Purpose: Rapid and accurate pathogen diagnosis is the key to the treatment of recurrent urinary tract infections (RUTI) after kidney transplant. Metagenomic next-generation sequencing (mNGS)…
2022 American Transplant Congress
Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience
N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Weight gain is common following organ transplantation, and there exists concern that in simultaneous pancreas-kidney (SPK) recipients, this may lead to poorer graft outcomes.*Methods:…
2022 American Transplant Congress
Post-Simultaneous Kidney and Pancreas Transplant Outcomes in Type 2 Diabetes Compared to Type 1 Diabetes
L. Liriano¹, Y. Al Azzi², S. Kapoor², S. Jain¹, M. Ajaimy³, P. Loarte², C. Pynadath⁴, J. Graham², S. Stefan¹, E. Akalin⁵
¹Montefiore Medical Center, Bronx, NY, ²Montefiore Medical Center, New York, NY, ³Montefiore-Einstein Transplant Center, Scarsdale, NY, ⁴Montefiore Medical Center, Scarsdale, NY, ⁵Albert Einstein College of Medicine, Montefiore Medical Ctr, Bronx, NY
*Purpose: To evaluate and compare short term and long-term outcomes in simultaneous kidney and pancreas transplant (SPK) recipients with a history of type 2 diabetes…
2022 American Transplant Congress
Evolving Trends In The Management And Outcome Of Duodenal Complications After Pancreas Transplantation: A 20-year Single Institution Experience
S. Ray¹, C. Parmentier¹, G. Sapisochin¹, A. Yousuf¹, I. McGilvray¹, A. Norgate¹, M. Cattral¹, M. Selzner², T. Reichman³
¹Multiorgan transplantation, Toronto general hospital, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³University of Toronto/The University Health Network, Toronto, ON, Canada
*Purpose: Duodenal leaks have been a sinister complication in any major gastro-intestinal operation. With an incidence ranging from 4-10%, these have been one of the…
2022 American Transplant Congress
Transitional-1 B Cell IL-10/TNFα Ratio Risk-Stratifies Renal Transplant Patients with Early Borderline Change
A. Cherukuri, P. Randhawa, S. Hariharan, D. Rothstein
Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA
*Purpose: Recent studies have shown that Banff borderline change (BLC) on allograft biopsies (Bx) is associated with decreased graft survival. However, many patients with BLC…
2022 American Transplant Congress
Outcome Predictors with Perioperative Kidney Transplant Midodrine Usage
R. Watson¹, S. Mullins², S. Williams³, F. Fakhre⁴, K. Robichaux⁴, S. Mohammed⁴, M. Gosselin³, A. Kumar⁵, J. Buggs¹, V. Bowers¹
¹Transplant Surgery, Tampa General Hospital, Tampa, FL, ²Florida A &M University, Tallahassee, FL, ³University of Tampa, Tampa, FL, ⁴University of South Florida, Tampa, FL, ⁵Morsani College of Medicine, University of South Florida, Tampa, FL
*Purpose: Midodrine is an alpha-1 agonist drug commonly used to aid hypotension in kidney transplant patients. Little is described regarding outcomes with midodrine in kidney…